Ekos

Ekos, a subsidiary of Boston Scientific, is a medical technology company that pioneered ultrasound-accelerated thrombolysis for the treatment of vascular blockages. Its flagship product, the EKOS Endovascular System, uses ultrasonic energy to thin fibrin strands within a blood clot, significantly increasing the surface area available for thrombolytic drugs to work. This mechanism allows for faster clot dissolution, lower drug dosages, and reduced bleeding risks compared to standard catheter-directed therapies. The system is FDA-cleared for the treatment of pulmonary embolism, deep vein thrombosis, and peripheral arterial occlusions. By integrating ultrasound with drug delivery, Ekos provides a minimally invasive solution for restoring blood flow in critical vascular conditions.